Exposing Pump and Dumps - All my own opinions / not financial advice
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Can't forget that mgmt, for the most part, all cashed out too!
*GILEAD:REMDESIVIR ASSOCIATED WITH 62% RISK CUT IN MORTALITY
Bye bye bag holders
They are pivoting away from COVID treatment as The Nader recently said there has been a lot of deaths in the trial. The NEJM data shows 5/6 Leronlimab treated individuals went to vents. The IL-6 wait no IL-5 wait no CCR5, wait no RANTES, drug doesn't work. If it did you would see a NVAX, INO, REGN, ASTRA type of govt deal or even 1. 1. Read again 1 single institutionals shareholder.
Buyerstrike Short Report
[url][/url][tag]https://buyersstrike.wordpress.com/2020/07/08/what-inane-nonsense-is-cytodyn-hyping-now-cydy/[/tag]
Well that means he had potential MNPI by communicating with Andrew Left right before the short happened but Andrew Left went short after the first crack so I don’t follow
Lol, dude, I’m not Tim. I wouldn’t be wasting my time on IHub if I had that kinda money. Tim bought the dip btw not caused the collapse, from what I see at least, and what’s posted on TWTR.
This is Called a PIVOT
CytoDyn’s Leronlimab Prevents Transmission of SHIV in Macaque Study
Results of preclinical study presented today in oral presentation at the 23rd
International AIDS Conference (AIDS 2020)
VANCOUVER, Washington, July 07, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc.
(OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage
biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist
with the potential clinical indications for HIV, COVID-19, cancer, GvHD and NASH
announced today the results from a preclinical macaque study evaluating
leronlimab as pre-exposure prophylaxis (PrEP) to prevent sexual HIV
transmission. The study evaluated the impact of a macaque-equivalent dose of
CytoDyn Cut to Neutral From Buy by HC Wainwright & Co.
either 350 mg (once weekly) or 700 mg (bi-monthly) leronlimab on acquisition
CytoDyn Cut to Neutral at HC Wainwright
of infection in a total of 18 animals, and found that the equivalent 700 mg bi-
CytoDyn Announces Execution of Exclusive Agreement with Amer
monthly leronlimab dose completely prevented rectal transmission of Simian-
RTT News: CytoDyn To Supply Leronlimab For Treatment Of COV
Human Immunodeficiency Virus (SHIV) in macaques. These results were
Trials and Tribulations Point to Ways to Save Covid Patients (1)
presented today in an oral presentation titled “CCR5 antibody blockade protects
rhesus macaques from rectal SHIV acquisition" at the 23rd International AIDS
Cellectis Falls After Study Halted Following Patient Death (1)
Conference (AIDS 2020).
“The results reported here in the preclinical macaque model of HIV sexual
Press Releases
transmission support leronlimab as a possible PrEP agent at a time when long-
But Leronlimab is an HIV drug....correct?
+ Leronlimab update from interview on 7/1 “so we have quite a bit of data, and Unfortunately quite a bit of death have been reported as a Serious Adverse Events which we get to see, we don’t get to see the data because it’s blinded, but we get to see the Serious Adverse Event”
• GILD secured European Commission approval to use Remdesivir in COVID patients (Reuters)
• GlaxoSmithKline and Sanofi strike GBP500M deal to supply the UK gov’t w/60M doses of their COVID vaccine (London Times)
So GILD is already going to be the stardard care...Gonna be tough to break into that market esp with the company being valued, fully diluted, at ~$5B
WHO halts trial of HIV drugs as possible treatment for patients hospitalized with coronavirus
https://www.cnbc.com/2020/07/04/coronavirus-who-halts-trial-of-two-hiv-drugs-lopinavir-ritonavir.html
This is not bullish...
HC is one of the biggest wh0res on the street. THey have buy ratings on actual frauds in hopes to do business with them. You can say it never mattered bu when HC put a buy rating and a huge PT on it the stock was up 20%. So logically the stock should be down on a downgrade also the stock seems to only be up bc of a 50k shares traded in Germany. The German pre-market daily pump is always faded so buyer beware
Citron reached out to me one hour before the report was released...
German listing - Can someone please share their thoughts on this one? It seems that people are buying the German listed company every monring, on small lots, to jack up the price on the US listed security. Has anyone looked into this?
Tim Sykes and Citron were not involved together. I know for a fact.
https://www.secform4.com/insider-trading/1175680.htm
Check out that image at the top with shares bought and sold. Pretty bullish!!!! LOL
You saw this with the ridiculous small lot orders happening every morning the last two weeks. On lot sizes of 1,000 they would bid up the stock 10%+ pre market. It was manipulation 101
I'm guessing you weren't on the Evercore/ISI call at 11 were you? The analyst was literally laughing at Herny's answers. They were super simple questions like, "which S subgroup does it bind to?" Herny actually said, "I don't know!" What a joke
Nobody touching this. This is a classic pump and dump. Sign of the times - SRNE has a cure - Wait…No, just another pump and dump J Capital Short Report from 2018 – also can’t forget the fake buyout in 1Q20 – also don’t forget in the past two months they filed a $250mm ATM with Alliance Global Partnergs (AGP) and $250mm purchase agreement with Anarki Ltd (BVI). And if that isn’t enough, “During the quarter ended March 31, 2020, the Company issued and sold an aggregate of 28,721,972 shares of the Company’s common stock to Aspire Capital for aggregate net proceeds to the Company of approximately $62.6 million. Subsequent to March 31, 2020, the Company issued and sold an aggregate of 5,103,038 shares of its common stock to Aspire Capital under the Aspire Purchase Agreement for aggregate net proceeds of approximately $12.4 million. On April 24, 2020, the Aspire Purchase Agreement terminated effective immediately in accordance with its terms as the Company issued and sold, as of such date, the full $75.0 million of shares available for issuance thereunder.” Still traded over 500mm shares and is a ~$1.5B mkt cap company. Where is the SEC?
Well you have to signficantly discount anything the CYDY PR PROMO team says bc of the mgmt's teams questionable past and that includes BP.
Also, GSK's aplaviroc, MRK's vicriviroc, and PFE's maraviroc are all CCR5 FDA approved drugs that are on the market and not being used. There is a livertox with one of these but that is only with prolonged usage not a few days for COVID treatment.
I am not saying the drug doesn't work and I really hope it does work miracles on the world so we can go back to normal life but I am skeptical bc of the already obvious and factual things in the market today. Again, this is not specuation, it is factual:
1) There are already CCR5s that are not being used,
2) mgmt swtiched from IL6 to ratnes,
3) mgmt sold lots of shares after massively overpaying themselves
4) mgmt is paying multiple promoters to promote the stock
5) First Medical is promoting and is owned by a know fraud
6) Nader himself was charged with fraud (dreamcathers) - if this isn't THE MOST TELLING I don't know what to tell you
7) Cool Blue capital were convicted frauds
My fault, I wasn't clear. There was one that cited (there a couple that site non-elevated levels) but there is no data bout rantes levels post given the drug.
Anyone ever ask the question why nobody is talking about rantees besides CYDY? Hint: It's not bc Nader found the panacea
Anyone ever ask the question why there have only been a couple papers with COVID that measure rantees and there were no elevated levels?
Anyone ever ask the question why when leronlimab was initiated (on day 0) in the 5 patients with elevated interleukin-6 levels; these levels decreased markedly 3 days later (range, 37 to 2022 pg per milliliter) (see Table S2 in the Supplementary Appendix). However, only the 1 patient who had the lowest interleukin-6 level (at 83 pg per milliliter) remained in stable condition without intubation.
Then they switched their drug from an IL6 to a rantees? COOL PIVOT!
These are just run of the mill questions. Let's not answer with "BC Big Pharma is Scared!" pls
You know Gilead is giving their drug away for free, right? Almost every other credible drug company has annouced if they find a treatment or vaccine they will give it away for free. So, why do you think that a) they can manufacture well given they've never had an approved drug; b) will be able to charge for it and; c) have the money to go through a trial?
Great research but failed to mention all studies were single arm, the CEO just dumped stock with the CMO, the CMO masquerading as "Quest" is not Quest Diagnostic but Quest Consulting, which has but one client, CYDY, and they're paying first medical news to pump the stock, along with dozens of others, which is owned by a convicted felon. Not to mention, and how ironic, that the CEO of CYDY was charged for selling, get this, fraudulent DREAMCATCHERS!!! You literally cannot make this crap up. Leronlimab doesn't work, will never work, and has no shot of beating out GILD or any other big companies drugs. I look forward to seeing Nader go down in cuffs shortly
NIAD and NIH published a paper yday that had no mention of Leronlimab but literally mentioned every other drug even Inovio, which is a classic pump and dump
Curious what about that article and the CMO pumping the stock now under the guise of "Quest" not the publicly traded Quest but a teeennniiieee tiny consulting Quest Clinical Research with CYDY as one of its only client.
CYDY and more felons
https://buyersstrike.wordpress.com/2020/05/11/whos-defending-cytodyn-now-hint-an-actual-felon-cydy/
Not to mention the presser tmw with the "Quest Diagnostics" is the former CMO of CYDY who once said he has no economic interests in CYDY. How are you guys this fking blind to outright fraud.
I'll buyback once its retrading after being suspended
It's because the jig is up. The company cannot sell more shares, has already diluted itself massively, and CEO and CMO sold the majority of their shares. This COVID drug, from a molecular standpoint, has no credibility. This is a classic pump and dump by Nader selling these silly bag holders a $2B EV dreamcatcher lol
Ughhh Blue Pool (largest investor) is a known fraud
https://img1.wsimg.com/blobby/go/cc91fda7-4669-4d1b-81ce-a0b8d77f25ab/downloads/Culper_CYDY_5-8-2020.pdf?ver=1588945434017
In light of Cool Blue’s substantial shareholding and continued participation in the Company’s numerous backdoor
offerings, Cool Blue / Conrad Brent Orr ought to be of interest to CytoDyn investors. As such, we were concerned
to uncover multiple allegations of fraud perpetrated by Brent Orr, including both a $50 million Ponzi scheme
and securities fraud involving claims to the recovery of “sunken and hidden treasure in the form of gold bullion.”
See the following from Orr’s alleged involvement in a $50 million Ponzi scheme:
The SEC gets closer and closer as P.T BarNADER, continues to go from retail investor to retail investor collecting money for tickets as he cashes out
COMPETING INTERESTS
Dr. Sacha has received compensation for consulting for CytoDyn Inc., a company that may have a commercial interest in the results of this research. The potential conflict of interest has been reviewed and managed by Oregon Health & Science University. Drs. Kelly and Pourhassan are employees of CytoDyn Inc., owner and developer of Leronlimab. Dr. Lalezari is a principal investigator for CytoDyn Inc. through his company Quest Clinical Research. Dr. Patterson, Brian Francisco, Amruta Pise, Matthew Ryou, Hallison Rodrigues are employees of IncellDx, Inc., a diagnostic company providing assays to Cytodyn Inc. Dr. Ndhlovu has received compensation for serving on a scientific advisory board for Abbvie. Lama Kdouh and Alina Lelic are employees of Beckman Coulter Life Sciences, and Monica Herrera and Eric Hall are employees of Bio-Rad, Inc. Drs. Kush Dhody and Kazem Kazempour are employees of Amarex Clinical Research, LLC, a company that manages clinical trials and regulatory matters for CytoDyn Inc.
Nothing to see here folks, nothing whatsoever to see LOL
I think most likely scenario is the SEC suspending the stock for fraud
Check my posts. When I claim a stock to be a fraud, I have never been wrong. This is fraud. Spin any story you want about the 144 filing, to uplist, proceeds to company, yada yada yada. The fact of the matter is the CEO is selling basically all of his shares while hiring dozens of promo pump and dumpers to pump this stock as he has almost daily "conference calls." You've been warmed.
Anyone in here up to date on the story? The stock has been a monster and looking for anyone who knows it well!
I actually made a couple shorts shorting BITCF into the pinks and covering at $0.2 Bc cost of borrow was $0.1 a month. This is a fraud / sub penny stock. Crazy you’re still involved!
No volume, fake price
It's dead
Crypto is dead. Nobody is investing in crypto start-ups
The primary Terms of the Agreement involve a Phase 1 collaboration between - to advice companies domiciled in the JV Jurisdiction with respect to business plans and proposed capital structuring that wish to raise capital through the issuance of an STO.
It won't. Don't worry. Crypto is dead and so is this thing
Fair value is about $1
1) Cost of borrow was not that high, I was paying about 10% annualized for about 6 months, but also traded it a bit and sized up in August. So let’s say it cost me 5% but my avg cost was $5.... and I just covered at $1.57
2) you’re very bad at math
3) your stock posts, which pumps, are public, And I suggest everyone reviews, are on stocks that eventually go down 99%....